Search research articles
Contact Us
Filters
Showing results (241-250 of 403) with videos related to
Page
of 41
Sort By:
Seminars in Arthritis and Rheumatism
|
June 17, 2026
Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CT
Simone T Willesen, Robert G W Lambert, Walter P Maksymowych, et al.
RMD Open
|
March 14, 2018
Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)
Féline P B Kroon, Charles G Peterfy, Philip G Conaghan, et al.
The American Journal of Gastroenterology
|
August 20, 2024
Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based Cohort
Nora Vladimirova, Jakob Møller, Mohamed Attauabi, et al.
Rheumatology (Oxford, England)
|
December 27, 2013
No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial
René Panduro Poggenborg, Charlotte Wiell, Pernille Bøyesen, et al.
Clinical and Experimental Rheumatology
|
March 30, 2023
Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis
Dženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
The Lancet. Rheumatology
|
November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study
Mikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
The Lancet. Rheumatology
|
May 4, 2026
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study
Mikkel Østergaard, Espen A Haavardsholm, Miroslawa Nowak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 19, 2015
Associations Between Spondyloarthritis Features and Magnetic Resonance Imaging Findings: A Cross-Sectional Analysis of 1,020 Patients With Persistent Low Back Pain
Bodil Arnbak, Anne Grethe Jurik, Kim Hørslev-Petersen, et al.
The Journal of Rheumatology
|
October 6, 2005
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment
Robert B M Landewé, Kay-Geert A Hermann, Désirée M F M van der Heijde, et al.
The Journal of Rheumatology
|
November 17, 2017
Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial
Jacob Sode, Sophine B Krintel, Anting Liu Carlsen, et al.
Page
of 41
Search research articles
Search
Showing results (241-250 of 403) with videos related to
Sort By:
Page
of 41
Seminars in Arthritis and Rheumatism
|
June 17, 2026
Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CT
Simone T Willesen, Robert G W Lambert, Walter P Maksymowych, et al.
RMD Open
|
March 14, 2018
Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)
Féline P B Kroon, Charles G Peterfy, Philip G Conaghan, et al.
The American Journal of Gastroenterology
|
August 20, 2024
Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based Cohort
Nora Vladimirova, Jakob Møller, Mohamed Attauabi, et al.
Rheumatology (Oxford, England)
|
December 27, 2013
No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial
René Panduro Poggenborg, Charlotte Wiell, Pernille Bøyesen, et al.
Clinical and Experimental Rheumatology
|
March 30, 2023
Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis
Dženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
The Lancet. Rheumatology
|
November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study
Mikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
The Lancet. Rheumatology
|
May 4, 2026
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study
Mikkel Østergaard, Espen A Haavardsholm, Miroslawa Nowak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 19, 2015
Associations Between Spondyloarthritis Features and Magnetic Resonance Imaging Findings: A Cross-Sectional Analysis of 1,020 Patients With Persistent Low Back Pain
Bodil Arnbak, Anne Grethe Jurik, Kim Hørslev-Petersen, et al.
The Journal of Rheumatology
|
October 6, 2005
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment
Robert B M Landewé, Kay-Geert A Hermann, Désirée M F M van der Heijde, et al.
The Journal of Rheumatology
|
November 17, 2017
Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial
Jacob Sode, Sophine B Krintel, Anting Liu Carlsen, et al.
Page
of 41